Therapeutic potential of human-induced pluripotent stem cell-derived endothelial cells in a bleomycin-induced scleroderma mouse model

Stem Cell Research

Volumn 10, Issue 3, 2013, Pages 288-300

  Azhdari, Manizheh ^a,b   Baghaban Eslaminejad, Mohamadreza ^a   Baharvand, Hossein ^a,b   Aghdami, Nasser ^a  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN; CD31 ANTIGEN; CD45 ANTIGEN; COLLAGEN TYPE 4; LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL SELECTION; EMBRYONIC STEM CELL DERIVED ENDOTHELIAL CELL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAST CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL DERIVED ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SKIN FIBROSIS; SPINDLE CELL; SYSTEMIC SCLEROSIS; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD31; BLEOMYCIN; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LIPOPROTEINS, LDL; MICE; MICE, INBRED BALB C; SCLERODERMA, SYSTEMIC; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84873642156     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2012.12.004     Document Type: Article

References (45)

1. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999, 85:221-228.
2. Baharvand H., Ashtiani S.K., Taee A., Massumi M., Valojerdi M.R., Yazdi P.E., Moradi S.Z., Farrokhi A. Generation of new human embryonic stem cell lines with diploid and triploid karyotypes. Develop. Growth Differ. 2006, 48:117-128.
3. Balconi G., Spagnuolo R., Dejana E. Development of endothelial cell lines from embryonic stem cells: a tool for studying genetically manipulated endothelial cells in vitro. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1443-1451.
4. Cipriani P., Guiducci S., Miniati I., Cinelli M., Urbani S., Marrelli A., Dolo V., Pavan A., Saccardi R., Tyndall A., Giacomelli R., Cerinic M.M. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum. 2007, 56:1994-2004.
5. Fleming J.N., Nash R.A., McLeod D.O., Fiorentino D.F., Shulman H.M., Connolly M.K., Molitor J.A., Henstorf G., Lafyatis R., Pritchard D.K., Adams L.D., Furst D.E., Schwartz S.M. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?. PLoS One 2008, 3:e1452.
6. Gabrielli A., Avvedimento E.V., Krieg T. Scleroderma. N. Engl. J. Med. 2009, 360:1989-2003.
7. Gonzalez F., Boue S., Belmonte J.C. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat. Rev. Genet. 2011, 12:231-242.
8. Heeschen C., Lehmann R., Honold J., Assmus B., Aicher A., Walter D.H., Martin H., Zeiher A.M., Dimmeler S. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109:1615-1622.
9. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003, 348:593-600.
10. Isner J.M., Kalka C., Kawamoto A., Asahara T. Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repair. Ann. N. Y. Acad. Sci. 2001, 953:75-84.
11. James D., Nam H.S., Seandel M., Nolan D., Janovitz T., Tomishima M., Studer L., Lee G., Lyden D., Benezra R., Zaninovic N., Rosenwaks Z., Rabbany S.Y., Rafii S. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nat. Biotechnol. 2010, 28:161-166.
12. Ji H., Ehrlich L.I., Seita J., Murakami P., Doi A., Lindau P., Lee H., Aryee M.J., Irizarry R.A., Kim K., Rossi D.J., Inlay M.A., Serwold T., Karsunky H., Ho L., Daley G.Q., Weissman I.L., Feinberg A.P. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 2010, 467:338-342.
13. Jinnin M., Ihn H., Yamane K., Tamaki K. Interleukin-13 stimulates the transcription of the human alpha2(I) collagen gene in human dermal fibroblasts. J. Biol. Chem. 2004, 279:41783-41791.
14. Kahaleh B. Vascular disease in scleroderma: mechanisms of vascular injury. Rheum. Dis. Clin. N. Am. 2008, 34:57-71. (vi).
15. Kane N.M., Meloni M., Spencer H.L., Craig M.A., Strehl R., Milligan G., Houslay M.D., Mountford J.C., Emanueli C., Baker A.H. Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1389-1397.
16. Kaufman D.S., Lewis R.L., Hanson E.T., Auerbach R., Plendl J., Thomson J.A. Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood 2004, 103:1325-1332.
17. Kim S., von Recum H.A. Endothelial progenitor populations in differentiating embryonic stem cells I: identification and differentiation kinetics. Tissue Eng. Part A 2009, 15:3709-3718.
18. Kim K., Doi A., Wen B., Ng K., Zhao R., Cahan P., Kim J., Aryee M.J., Ji H., Ehrlich L.I., Yabuuchi A., Takeuchi A., Cunniff K.C., Hongguang H., McKinney-Freeman S., Naveiras O., Yoon T.J., Irizarry R.A., Jung N., Seita J., Hanna J., Murakami P., Jaenisch R., Weissleder R., Orkin S.H., Weissman I.L., Feinberg A.P., Daley G.Q. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290.
19. Levenberg S., Golub J.S., Amit M., Itskovitz-Eldor J., Langer R. Endothelial cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:4391-4396.
20. Levenberg S., Ferreira L.S., Chen-Konak L., Kraehenbuehl T.P., Langer R. Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells. Nat. Protoc. 2010, 5:1115-1126.
21. Li Z., Wu J.C., Sheikh A.Y., Kraft D., Cao F., Xie X., Patel M., Gambhir S.S., Robbins R.C., Cooke J.P., Wu J.C. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 2007, 116:I46-I54.
22. Li Z., Wilson K.D., Smith B., Kraft D.L., Jia F., Huang M., Xie X., Robbins R.C., Gambhir S.S., Weissman I.L., Wu J.C. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS One 2009, 4:e8443.
23. Li Z., Hu S., Ghosh Z., Han Z., Wu J.C. Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells. Stem Cells Dev. 2011, 20:1701-1710.
24. Lister R., Pelizzola M., Kida Y.S., Hawkins R.D., Nery J.R., Hon G., Antosiewicz-Bourget J., O'Malley R., Castanon R., Klugman S., Downes M., Yu R., Stewart R., Ren B., Thomson J.A., Evans R.M., Ecker J.R. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011, 471:68-73.
25. Marchetto M.C., Yeo G.W., Kainohana O., Marsala M., Gage F.H., Muotri A.R. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 2009, 4:e7076.
26. Nourse M.B., Halpin D.E., Scatena M., Mortisen D.J., Tulloch N.L., Hauch K.D., Torok-Storb B., Ratner B.D., Pabon L., Murry C.E. VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler. Thromb. Vasc. Biol. 2010, 30:80-89.
27. Polo J.M., Liu S., Figueroa M.E., Kulalert W., Eminli S., Tan K.Y., Apostolou E., Stadtfeld M., Li Y., Shioda T., Natesan S., Wagers A.J., Melnick A., Evans T., Hochedlinger K. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 2010, 28:848-855.
28. Reinecke H., Murry C.E. Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. J. Mol. Cell. Cardiol. 2002, 34:251-253.
29. + endothelial progenitor cells for cardiac repair. Regen. Med. 2010, 5:231-244.
30. Rufaihah A.J., Huang N.F., Jame S., Lee J.C., Nguyen H.N., Byers B., De A., Okogbaa J., Rollins M., Reijo-Pera R., Gambhir S.S., Cooke J.P. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler. Thromb. Vasc. Biol. 2011, 31:e72-e79.
31. Seifinejad A., Tabebordbar M., Baharvand H., Boyer L.A., Salekdeh G.H. Progress and promise towards safe induced pluripotent stem cells for therapy. Stem Cell Rev. 2010, 6:297-306.
32. Sone M., Itoh H., Yamashita J., Yurugi-Kobayashi T., Suzuki Y., Kondo Y., Nonoguchi A., Sawada N., Yamahara K., Miyashita K., Park K., Shibuya M., Nito S., Nishikawa S., Nakao K. Different differentiation kinetics of vascular progenitor cells in primate and mouse embryonic stem cells. Circulation 2003, 107:2085-2088.
33. Sone M., Itoh H., Yamahara K., Yamashita J.K., Yurugi-Kobayashi T., Nonoguchi A., Suzuki Y., Chao T.H., Sawada N., Fukunaga Y., Miyashita K., Park K., Oyamada N., Sawada N., Taura D., Tamura N., Kondo Y., Nito S., Suemori H., Nakatsuji N., Nishikawa S., Nakao K. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2127-2134.
34. Stadtfeld M., Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev. 2010, 24:2239-2263.
35. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
36. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
37. Totonchi M., Taei A., Seifinejad A., Tabebordbar M., Rassouli H., Farrokhi A., Gourabi H., Aghdami N., Hosseini-Salekdeh G., Baharvand H. Feeder- and serum-free establishment and expansion of human induced pluripotent stem cells. Int. J. Dev. Biol. 2010, 54:877-886.
38. Trojanowska M. Cellular and molecular aspects of vascular dysfunction in systemic sclerosis. Nat. Rev. Rheumatol. 2010, 6:453-460.
39. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 2001, 89:E1-E7.
40. Voyta J.C., Via D.P., Butterfield C.E., Zetter B.R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 1984, 99:2034-2040.
41. Yamamoto T. Scleroderma-pathophysiology. Eur. J. Dermatol. 2009, 19:14-24.
42. Yamamoto T. Animal model of systemic sclerosis. J. Dermatol. 2010, 37:26-41.
43. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., Naito M., Nakao K., Nishikawa S. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000, 408:92-96.
44. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
45. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-215.